GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » Cyclically Adjusted PS Ratio

Joinn Laboratories (China) Co (SHSE:603127) Cyclically Adjusted PS Ratio : 11.84 (As of Apr. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co Cyclically Adjusted PS Ratio?

As of today (2024-04-29), Joinn Laboratories (China) Co's current share price is ¥16.57. Joinn Laboratories (China) Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was ¥1.40. Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio for today is 11.84.

The historical rank and industry rank for Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:603127' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 11.1   Med: 36.06   Max: 71.37
Current: 12.37

During the past 12 years, Joinn Laboratories (China) Co's highest Cyclically Adjusted PS Ratio was 71.37. The lowest was 11.10. And the median was 36.06.

SHSE:603127's Cyclically Adjusted PS Ratio is ranked worse than
88.97% of 136 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.235 vs SHSE:603127: 12.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Joinn Laboratories (China) Co's adjusted revenue per share data of for the fiscal year that ended in Dec23 was ¥3.173. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥1.40 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Joinn Laboratories (China) Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Cyclically Adjusted PS Ratio Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 70.42 37.02 16.89

Joinn Laboratories (China) Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.02 - - - 16.89

Competitive Comparison of Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio falls into.



Joinn Laboratories (China) Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.57/1.4
=11.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joinn Laboratories (China) Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Joinn Laboratories (China) Co's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=3.173/114.6694*114.6694
=3.173

Current CPI (Dec23) = 114.6694.

Joinn Laboratories (China) Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.401 99.000 0.464
201512 0.446 100.600 0.508
201612 0.522 102.600 0.583
201712 0.586 104.500 0.643
201812 0.658 106.500 0.708
201912 1.035 111.200 1.067
202012 1.725 111.500 1.774
202112 2.079 113.108 2.108
202212 3.019 115.116 3.007
202312 3.173 114.669 3.173

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Joinn Laboratories (China) Co  (SHSE:603127) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Joinn Laboratories (China) Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co (SHSE:603127) Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines